Plain-English translation of NCT05460143 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at the University of Cambridge are using a portable brain-imaging device called Near-Infrared Spectroscopy (NIRS) to better understand how different types of dementia affect the brain. This device uses harmless light to measure blood flow and oxygen levels in the brain while you do simple thinking tasks. The study aims to help doctors diagnose dementia more accurately and understand why these diseases happen.
Currently, doctors struggle to tell different types of dementia apart because they share similar symptoms, and many people are misdiagnosed. This trial exists to find objective, measurable differences in how the brain functions across different types of dementia, which could lead to better and earlier diagnosis.
You likely qualify if…
You likely don't qualify if…
You will visit the research center where researchers will place a special light-sensing cap on your head to measure brain activity. While wearing this device, you'll complete several thinking tasks like memory tests, attention exercises, and simple physical tasks. The whole visit typically takes a few hours, and you may be asked to return for additional sessions so researchers can use different types of brain imaging.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
United Kingdom